Patients with Down's syndrome die at an earlier age than other people of the same sex and race (Carter, 1958; Collmann and Stoller, 1963; Benda, 1969; Fabia and Drolette, 1970; Deaton, 1973; 0ster et al., 1975) . In addition, we have reason to believe that if these patients had exactly the same genomes as they have, except for trisomy at chromosome 21, they would live as long as other people. In general terms, therefore, it makes sense to say that Down's syndrome is a life-shortening condition or that because of it so many years of life are lost. Any attempt to be more specific, however, runs into difficulty because Down's syndrome is not a cause of death in the usual sense, and does not satisfy the assumptions implicit in the accepted actuarial procedures for calculating years of life lost (Jordan, 1952) . The purpose of this paper is, first, to consider how, in general, years of life lost should be calculated for a congenital genetic condition, and then to carry out such a calculation for Down's syndrome. A concluding section discusses prenatal mortality because of trisomy 21.
Years of life lost
Years of life lost is ordinarily calculated for a cause Received for publication 6 December 1978 of death as given in the international classification of causes of death (World Health Organization, 1977 (Cornfield, 1957; Gail, 1975 (Dempsey, 1947; Fielding and Walsh, 1976 ). This procedure is incorrect (Greville, 1948 ) because a person aged 44 has already survived many risks of death and can expect to live to an appreciably riper age than he could have as a newborn.
A congenital genetic condition differs from a traditional cause of death in two basic ways. Firstly, it can be taken to act continuously from the moment of birth. Secondly, it does not act as a cause of death but, rather, as a risk-altering state. The age specific risks of death from pneumonia, for example, are much greater for patients with Down's syndrome than they are for other people, especially in adolescence (0ster et al., 1975, Table 4 ). The age specific risks of death from heart disease are also greatly raised among people with Down's syndrome, again in adolescence especially, but even more so in childhood (0ster et al., 1975, Formulas (1) and (2), and the reasoning that underlies them, apply to genetic conditions which manifest themselves at birth only. Diseases with delayed onset require special treatment.
Down's syndrome
The incidence of Down's syndrome in the UK at birth has been reliably estimated as 1 in 660 (Carter and MacCarthy, 1951) . Amniocentesis might easily change this figure but as of 1970, the date we will use for our calculations, this figure was still generally accepted for the US also (Nora and Fraser, 1974) .
Superficially, the sex distribution at birth appears slightly to favour the males. Record and Smith (1955) reported that in a series of 252 persons born with Down's syndrome in Birmingham, England, 55 4% were male and 44*6 % were female. Most of the evidence, however, supports the view that in early infancy especially, but to some extent throughout the first year of life, female infants with Down's syndrome die at a greater rate than their male counterparts (Carter, 1958; Collmann and Stoller, 1963; Forssman and Akesson, 1965; Fabia and Drolette, 1970) . Therefore, any failure of ascertainment in the first few days or weeks after birth will lead to overestimation of the sex ratio at birth. Record and Smith (1955) believed that an error of this sort was involved in their own data. In their opinion, the sex ratio at birth which they obtained was 'probably too high'. We will proceed, therefore, on the assumption that with complete ascertainment at birth, male and female neonates with Down's syndrome would be of equal numbers.
Life expectancy among patients with Down's syndrome has increased in the last three or four decades. In 1954, the average age at death of persons with Down's syndrome in institutions in Australia was slightly over 10 years (Brothers and Jago, 1954) . In 1961, also in Australia, the average age at death was 16-2 years (Collmann and Stoller, 1963) . Benda (1969) The Table presents the number surviving (lx) and the number dying (dx) per 100 births with Down's syndrome for single years up to 4-and 5-year intervals thereafter. For 0 to 9 years of age the figures are calculated from Fabia and Drolette (1970) , thereafter from 0ster et al. (1975) . The average age at death for those patients who died in infancy was 4 months for both sexes (Fabia and Drolette, 1970) . Assuming that otherwise all deaths are distributed uniformly over their respective age intervals, the average age at death for males is 35X7 and for females 35 5. In 1970, life expectancy at birth in the general United States population was 67 1 years for males and 74-8 years for females (National Center for Health Statistics, 1974) . Therefore, applying equation (2) (Hemminki et al., 1976) . It is on this basis that vascular disease is often said to be the most serious health problem in the USA today (for example, Wetzler, 1976) . In certain circumstances, however, years of life lost or closely related statistics may also be used to assess the costs or benefits of particular forms of medical intervention. We have just determined that a liveborn child with Down's syndrome can expect to live 35 -6 years. It follows that induced abortion after amniocentesis, occurring as it now does toward the end of the second trimester of pregnancy (Omenn, 1978) 
